Genenta Science SPA (GNTA) Stock Price, Quote, News & History

GNTANASDAQ
$1.80
-0.07-3.74%
At close: Jun 15, 5:00 PM EST
$1.79
-0.0069-0.38%
After Hours: 4:12 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.87M
Investing Cash Flow (TTM)
-14.54M
Financing Cash Flow (TTM)
22.29M
Free Cash Flow (TTM)
-6.88M
Capital Expenditure (TTM)
-7.63K
Net Change in Cash (TTM)
875.56K

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$19.74M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.73
Earnings Yield % (TTM)
-20.63%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.07

Company Debt

Total Debt
$7.60M
LT Debt
$7.60M
LT Debt Issuance (TTM)
$7.50M
LT Debt Repayment (TTM)
-
Total Cash
$5.53M
Debt to Equity
0.35
Issuance of Debt (TTM)
$7.50M
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.90
Close
$1.80
Volume / Avg.
229.67K / 1.38M
Day Range
$1.76 - $1.90
52 Wk Range
0.55 - 10.00
Market Cap
$42.02M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
1.91%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Genenta Science (GNTA) stock?

A

You can purchase shares of Genenta Science (NASDAQ:GNTA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Genenta Science (GNTA) competitors?

A

There are no as such competitors for Genenta Science.

Q

What is the forecast, or price target, for Genenta Science (GNTA) stock?

A

Genenta Science has a consensus price target of $20.00.

Q

What is the current price for Genenta Science (GNTA)?

A

The stock price for Genenta Science (NASDAQ: GNTA) is $1.7931 last updated June 15, 2026 at 4:12 PM EDT.

Q

Does Genenta Science (GNTA) pay a dividend?

A

There are no upcoming dividends for Genenta Science.

Q

When is Genenta Science (NASDAQ:GNTA) reporting earnings?

A

Genenta Science does not have any upcoming earnings scheduled.

Q

Is Genenta Science (GNTA) going to split?

A

There is no upcoming split for Genenta Science.

Q

What sector and industry does Genenta Science (GNTA) operate in?

A

Genenta Science is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.